Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Micaela B Reddy

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Clinical Pharmacokinetics|February 29, 2024
Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin CoadministrationJoseph Piscitelli, Micaela B Reddy, Lance Wollenberg, et al.
Plos One|October 14, 2015
Oseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study DesignMicaela B Reddy, Kuo-Hsiung Yang, Gauri Rao, et al.
Biopharmaceutics & Drug Disposition|June 11, 2011
Physiological modeling and assessments of regional drug bioavailability of danoprevir to determine whether a controlled release formulation is feasibleMicaela B Reddy, Alyson Connor, Barbara J Brennan, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 21, 2015
Investigating the effect of autoinduction in cynomolgus monkeys of a novel anticancer MDM2 antagonist, idasanutlin, and relevance to humansKelli J Glenn, Li J Yu, Micaela B Reddy, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 28, 2008
Inhalation dosimetry modeling with decamethylcyclopentasiloxane in rats and humansMicaela B Reddy, Ivan D Dobrev, Debra A McNett, et al.
Pharmaceutics|September 28, 2021
PBPK Modeling as a Tool for Predicting and Understanding Intestinal Metabolism of Uridine 5'-Diphospho-glucuronosyltransferase SubstratesMicaela B Reddy, Michael B Bolger, Grace Fraczkiewicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2022
Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant MelanomaMartin Schuler, Lisa Zimmer, Kevin B Kim, et al.
Clinical Pharmacology and Therapeutics|October 18, 2024
Building Confidence in Physiologically Based Pharmacokinetic Modeling of CYP3A Induction Mediated by Rifampin: An Industry PerspectiveMicaela B Reddy, Tamara D Cabalu, Loeckie de Zwart, et al.
Clinical Pharmacology and Therapeutics|December 4, 2021
Current Practices, Gap Analysis, and Proposed Workflows for PBPK Modeling of Cytochrome P450 Induction: An Industry PerspectiveNiresh Hariparsad, Diane Ramsden, Kunal Taskar, et al.
Cancer Discovery|June 3, 2023
SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted TherapyAlexander Drilon, Manish R Sharma, Melissa L Johnson, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Clinical Pharmacokinetics|February 29, 2024
Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin CoadministrationJoseph Piscitelli, Micaela B Reddy, Lance Wollenberg, et al.
Plos One|October 14, 2015
Oseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study DesignMicaela B Reddy, Kuo-Hsiung Yang, Gauri Rao, et al.
Biopharmaceutics & Drug Disposition|June 11, 2011
Physiological modeling and assessments of regional drug bioavailability of danoprevir to determine whether a controlled release formulation is feasibleMicaela B Reddy, Alyson Connor, Barbara J Brennan, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 21, 2015
Investigating the effect of autoinduction in cynomolgus monkeys of a novel anticancer MDM2 antagonist, idasanutlin, and relevance to humansKelli J Glenn, Li J Yu, Micaela B Reddy, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 28, 2008
Inhalation dosimetry modeling with decamethylcyclopentasiloxane in rats and humansMicaela B Reddy, Ivan D Dobrev, Debra A McNett, et al.
Pharmaceutics|September 28, 2021
PBPK Modeling as a Tool for Predicting and Understanding Intestinal Metabolism of Uridine 5'-Diphospho-glucuronosyltransferase SubstratesMicaela B Reddy, Michael B Bolger, Grace Fraczkiewicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2022
Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant MelanomaMartin Schuler, Lisa Zimmer, Kevin B Kim, et al.
Clinical Pharmacology and Therapeutics|October 18, 2024
Building Confidence in Physiologically Based Pharmacokinetic Modeling of CYP3A Induction Mediated by Rifampin: An Industry PerspectiveMicaela B Reddy, Tamara D Cabalu, Loeckie de Zwart, et al.
Clinical Pharmacology and Therapeutics|December 4, 2021
Current Practices, Gap Analysis, and Proposed Workflows for PBPK Modeling of Cytochrome P450 Induction: An Industry PerspectiveNiresh Hariparsad, Diane Ramsden, Kunal Taskar, et al.
Cancer Discovery|June 3, 2023
SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted TherapyAlexander Drilon, Manish R Sharma, Melissa L Johnson, et al.
Pageof 4